RecruitingNot ApplicableNCT07155707

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings


Sponsor

Stanford University

Enrollment

156 participants

Start Date

Jun 24, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.


Eligibility

Min Age: 5 YearsMax Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Standard Videoconferencing and Teleo for people with anxiety and mood disorders. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 5 Years to 14 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTeleo

Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

OTHERStandard Videoconferencing

Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.


Locations(2)

Ohana Center for Child and Adolescent Behavioral Health

Monterey, California, United States

Stanford University

Stanford, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07155707


Related Trials